| Literature DB >> 31928915 |
Sirajum Munira1, Lisa Christopher-Stine2.
Abstract
Myositis and scleroderma are both rare autoimmune diseases with female predominance and often occur before and during reproductive years. The rarity of diseases explains the low frequency of concurrent disease and pregnancy. Like other autoimmune diseases, myositis and scleroderma may be more active during pregnancy as well. To date, many patients with myositis and scleroderma can have favorable pregnancy outcomes with careful management. This chapter provides a current overview of pregnancy outcomes in myositis and scleroderma. A major theme that appears to have emerged across these inflammatory diseases is that active maternal disease during pregnancy is associated with adverse pregnancy outcomes, and thus, personalized management is necessary depending on the disease state and comorbidities.Entities:
Keywords: Idiopathic inflammatory myopathies; Myositis; Pregnancy; Reproductive health; Scleroderma
Mesh:
Substances:
Year: 2019 PMID: 31928915 DOI: 10.1016/j.bpobgyn.2019.10.004
Source DB: PubMed Journal: Best Pract Res Clin Obstet Gynaecol ISSN: 1521-6934 Impact factor: 5.237